BioChain has long been providing large amounts of cfDNA (nanogram to microgram scales) over the years to researchers upon request. However, demand has greatly accelerated in recent years. Therefore, BioChain is now offering high-quality human plasma cfDNA from a pool of healthy/normal individuals for use as a reference control and standard. As opposed to synthetic or mixtures of cell line DNAs, this endogenous cfDNA will serve as an impartial baseline/reference to cell-free circulating tumor DNA for various diseases in human.
Features:
Human plasma cfDNA isolated from a pool of healthy/normal donors
Negligible traces of genomic DNA
cfDNA validated by BioAnalyzer and concentration determined by Qubit dsDNA high sensitivity kit
Applications:
Ideal PCR and NGS control for mutational analysis and biomarker discovery to cell-free circulating tumor DNA or other diseases
Protocol optimization for cfDNA extraction
QC standards
Companion diagnostics development
Gene and protein expression analysis
Immunohistochemistry (IHC) and In situ hybridization (ISH)